Late-onset immune thrombocytopenia after unrelated cord blood transplantation for chronic myelomonocytic leukemia

Several reports have been published on autoimmune hematologic complications, including immune thrombocytopenia (ITP), after cord blood transplantation (CBT). However, there have been no reports of late-onset ITP following CBT. A 51-year-old male with chronic myelomonocytic leukemia received unrelated CBT in 2012. During regular follow-up visits every 3-6 months, his complete blood count remained normal until March 2024. In September 2024, 12 years after the CBT, the patient suddenly developed severe thrombocytopenia. Following a diagnosis of ITP, the patient was treated with intravenous immunoglobulins and prednisone. With follow-up period of 5 months after the onset of ITP, the patient is still alive with a platelet count of 126 × 10<sup>9</sup>/L. This case suggests that late-onset ITP after CBT occurred suddenly and may be life-threatening. Long-term follow-ups and regular clinic visits may reduce the risk of delays in diagnosis and treatment.

Authors

Institutions

Publication Details

Journal
BLOOD CELL THERAPY / The official journal of APBMT
Published
2025-01-01
DOI
https://doi.org/10.31547/bct-2025-004
Primary Topic
Chronic Myeloid Leukemia Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Late-onset immune thrombocytopenia after unrelated cord blood transplantation for chronic myelomonocytic leukemia

Haruko Tashiro, Jun Ooi, Kensuke Matsumoto, Shoya Arai et al.
1 links
BLOOD CELL THERAPY / The official journal of APBMT
Chronic Myeloid Leukemia Treatments
article

Late-onset immune thrombocytopenia after unrelated cord blood transplantation for chronic myelomonocytic leukemia

Haruko Tashiro, Jun Ooi, Kensuke Matsumoto, Shoya Arai, Takaaki Konuma, Seiko Kato
article en

Abstract

Several reports have been published on autoimmune hematologic complications, including immune thrombocytopenia (ITP), after cord blood transplantation (CBT). However, there have been no reports of late-onset ITP following CBT. A 51-year-old male with chronic myelomonocytic leukemia received unrelated CBT in 2012. During regular follow-up visits every 3-6 months, his complete blood count remained normal until March 2024. In September 2024, 12 years after the CBT, the patient suddenly developed severe thrombocytopenia. Following a diagnosis of ITP, the patient was treated with intravenous immunoglobulins and prednisone. With follow-up period of 5 months after the onset of ITP, the patient is still alive with a platelet count of 126 × 10<sup>9</sup>/L. This case suggests that late-onset ITP after CBT occurred suddenly and may be life-threatening. Long-term follow-ups and regular clinic visits may reduce the risk of delays in diagnosis and treatment.

BLOOD CELL THERAPY / The official journal of APBMTVol. 8(3)
The University of Tokyo (JP), Teikyo University (JP)
Good health and well-being
Openalex Percentile: Top 78%
Chronic Myeloid Leukemia Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.